Investing.com - KORU Medical Systems (NASDAQ: KRMD) reported first quarter EPS of $-0.050, in line with the analyst estimate of $-0.050. Revenue for the quarter came in at $7.4M versus the...
Repro Med Systems (KRMD) reported Q4 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $7.34 million versus the consensus estimate of...
Investing.com - KORU Medical Systems (NASDAQ: KRMD) reported first quarter EPS of $-0.040, $0.02 better than the analyst estimate of $-0.060. Revenue for the quarter came in at $7.34M versus...
Investing.com - KORU Medical Systems reported on Wednesday third quarter {{erl-1131518||earnings that beat analysts' forecasts and revenue that topped expectations. KORU Medical Systems...
Repro Med Systems (KRMD) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $7.76 million versus the consensus estimate of $6.7...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Utilities, Financials and Industrials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Consumer Services, Technology and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Technology, Healthcare and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
